We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

StageZero Life Sciences Ltd (SZLS) NPV

Sell:0.35 CAD Buy:0.35 CAD Change: 0.01 CAD (2.90%)
Market closed |  Prices as at close on 27 October 2021 | Switch to live prices |
Sell:0.35 CAD
Buy:0.35 CAD
Change: 0.01 CAD (2.90%)
Market closed |  Prices as at close on 27 October 2021 | Switch to live prices |
Sell:0.35 CAD
Buy:0.35 CAD
Change: 0.01 CAD (2.90%)
Market closed |  Prices as at close on 27 October 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

StageZero Life Sciences Ltd. is a Canada-based company focused on developing and commercializing molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual’s current risk for having colorectal cancer. It is developing cancer testing kit Aristotle, which is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. The Company is also focused on testing Aristotle application on other disease conditions including neurology, gastroenterology, cardiology, and autoimmune disorders.

Contact details

Address:
70 East Beaver Creek Rd, Unit 30
RICHMOND HILL
L4B 3B2
Canada
Telephone:
+1 (905) 2092030
Website:
https://www.stagezerolifesciences.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SZLS
ISIN:
CA8525403017
Market cap:
27.63 million CAD
Shares in issue:
78.86 million
Sector:
Biotechnology
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • James Howardtripp
    Independent Chairman of the Board, Chief Executive Officer
  • Matthew Pietras
    Chief Financial Officer, Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.